Agent for treating bradycardia and bradyarrhythmia

Details Agent for treating bradycardia and bradyarrhythmia Agent for treating bradycardia and bradyarrhythmia

1989-01-17

1990-02-27

Rose, Shep K.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

A61K 31445

Patent

active

049046730

ABSTRACT:
(.+-.)-1-[4-[Ethyl[2-(4-methoxyphenyl)-1-methylethyl]-amino]-1-oxobutyl]-N, N-dimethyl-4-piperidine carboxamide and (+)-1-[4-[ethyl[2-(4-methoxyphenyl)-1-methylethyl]-amino]-1-oxobutyl]N,N-d imethyl-4-piperidinecarboxamide, as well as the physiologically acceptable acid addition salts of these compounds are suitable for the treatment of bradycardia and bradyarrhythmia.

REFERENCES:
patent: 4547514 (1985-10-01), Mathur
patent: 4560692 (1985-12-01), Field
De Bree, CA. 110:224807w (1988).
Van Der Stel, CA. 110:204964s (1988).
Buffington, CA. 110:147636k (1989).
Bigler, CA. 106:107814c (1986).
Thomas, CA. 106:12842w (1986).

Affiliated with

Also associated with

Rating

Agent for treating bradycardia and bradyarrhythmia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Agent for treating bradycardia and bradyarrhythmia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agent for treating bradycardia and bradyarrhythmia will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-174452